ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000255421.1	Avagacestat	Head and neck squamous cell carcinoma	0.00077283	Resistant
ENSG00000255421.1	Avagacestat	Bladder urothelial carcinoma	0.042927497	Sensitive